Geoffrey von Maltzahn's most recent trade in Sana Biotechnology Inc was a trade of 1,464,488 Common Stock done . Disclosure was reported to the exchange on Feb. 8, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sana Biotechnology Inc | Geoffrey von Maltzahn | Director | 08 Feb 2021 | 1,464,488 | 1,464,488 | - | - | Common Stock | ||
| Sana Biotechnology Inc | Geoffrey von Maltzahn | Director | 08 Feb 2021 | 1,464,488 | 0 | - | - | Series A-2 Convertible Preferred Stock | ||
| Sana Biotechnology Inc | Geoffrey von Maltzahn | Director | 08 Feb 2021 | 366,122 | 366,122 | - | - | Common Stock | ||
| Sana Biotechnology Inc | Geoffrey von Maltzahn | Director | 08 Feb 2021 | 366,122 | 0 | - | - | Series A-2 Convertible Preferred Stock | ||
| Sana Biotechnology Inc | Geoffrey von Maltzahn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 23,591 | 23,591 | - | - | Stock Option (Right to Buy) |